Literature DB >> 19277835

Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.

Ravi Gupta1, Tanzeel Ahmed, Basudeb Banerjee, Manjeet Bhatia.   

Abstract

Calcitonin gene-related peptide (CGRP) is known to increase during acute attack of migraine and tension type headache (TTH). However, its concentration during inter-ictal period is not known. This may help us to understand the pathophysiology of these headaches. The objectives of this study are to find out the concentration of CGRP in plasma during inter-ictal period among migraineurs and TTH and to compare it with control group through cross-sectional study from headache clinic of a tertiary centre. Study sample comprised of three groups: migraineurs, TTH subjects as well as a healthy control group. Fifty subjects in each group were included after screening for the respective inclusion criteria and exclusion criteria. None of the subjects was blood relatives of other subject. Their venous blood was drawn and plasma was separated to be kept at -70 degrees C. CGRP was analysed with commercially available ELISA kit. Data were analysed with the help of SPSS V 11.0 for Windows. Chi-square, independent sample t test and one-way ANOVA with post hoc Tukey and univariate regression were performed. Plasma CGRP concentration was not different among three diagnostic groups (F = 0.78; P = 0.49). Similarly, plasma CGRP concentration was not different among episodic TTH and chronic TTH groups (t = 0.32; P = 0.97) and comparison of episodic and chronic migraine groups also revealed similar results in this study (1.14 vs. 0.94 ng/ml; P = 0.23). The presence of aura did not affect the inter-ictal CGRP levels among migraineurs (F = 0.16; P = 0.85). In conclusion, this study suggests that migraine and TTH could be episodic disorders and subjects have comparable CGRP levels during inter-ictal period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277835      PMCID: PMC3451985          DOI: 10.1007/s10194-009-0110-x

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  36 in total

1.  No increase of calcitonin gene-related peptide in jugular blood during migraine.

Authors:  Jesper Filtenborg Tvedskov; Kerstin Lipka; Messoud Ashina; Helle K Iversen; Søren Schifter; Jes Olesen
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

2.  Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.

Authors:  Emi Fusayasu; Hisanori Kowa; Takao Takeshima; Kazuhiro Nakaso; Kenji Nakashima
Journal:  Pain       Date:  2006-11-22       Impact factor: 6.961

Review 3.  Cerebral blood flow changes in the different phases of migraine.

Authors:  Marco Bartolini; Roberto Baruffaldi; Isabella Paolino; Mauro Silvestrini
Journal:  Funct Neurol       Date:  2005 Oct-Dec

Review 4.  Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?

Authors:  G Coppola; F Pierelli; J Schoenen
Journal:  Cephalalgia       Date:  2007-12       Impact factor: 6.292

Review 5.  CGRP antagonists: unravelling the role of CGRP in migraine.

Authors:  Henri Doods; Kirsten Arndt; Klaus Rudolf; Stefan Just
Journal:  Trends Pharmacol Sci       Date:  2007-10-25       Impact factor: 14.819

Review 6.  Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors:  Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

7.  Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells.

Authors:  Jing Li; Carrie V Vause; Paul L Durham
Journal:  Brain Res       Date:  2008-01-25       Impact factor: 3.252

8.  Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology.

Authors:  Srikanth Thalakoti; Vinit V Patil; Srikanth Damodaram; Carrie V Vause; Lauren E Langford; Stacy E Freeman; Paul L Durham
Journal:  Headache       Date:  2007 Jul-Aug       Impact factor: 5.887

Review 9.  Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.

Authors:  Lars Edvinsson
Journal:  Expert Opin Ther Targets       Date:  2007-09       Impact factor: 6.902

Review 10.  Calcitonin gene-related peptide in tension-type headache.

Authors:  M Ashina
Journal:  ScientificWorldJournal       Date:  2002-06-07
View more
  7 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Future drugs for migraine.

Authors:  Luigi Alberto Pini
Journal:  Intern Emerg Med       Date:  2009-08-26       Impact factor: 3.397

Review 3.  Tension-type headache.

Authors:  Sait Ashina; Dimos D Mitsikostas; Mi Ji Lee; Nooshin Yamani; Shuu-Jiun Wang; Roberta Messina; Håkan Ashina; Dawn C Buse; Patricia Pozo-Rosich; Rigmor H Jensen; Hans-Christoph Diener; Richard B Lipton
Journal:  Nat Rev Dis Primers       Date:  2021-03-25       Impact factor: 52.329

Review 4.  Future drugs for migraine.

Authors:  Ivano Farinelli; Sergio De Filippis; Gabriella Coloprisco; Serena Missori; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2009-06-24       Impact factor: 3.397

5.  Plasma calcitonin gene-related peptide (CGRP) in migraine and endometriosis during the menstrual cycle.

Authors:  Bianca Raffaelli; Lucas Hendrik Overeem; Jasper Mecklenburg; Maxi Dana Hofacker; Henriette Knoth; Claus Peter Nowak; Lars Neeb; Andreas Dietmar Ebert; Jalid Sehouli; Sylvia Mechsner; Uwe Reuter
Journal:  Ann Clin Transl Neurol       Date:  2021-05-02       Impact factor: 4.511

6.  CALCB rs3829222 T/T Genotype and Low Expression of CALCB Are High-Risk Factors for Adenoid Cystic Carcinoma of Salivary Gland.

Authors:  Chaobin Dai; Bin Zhang; Yunyang Liao; Qicai Liu; Feiguang Wu; Xiaoting Lv; Kai Zeng; Xiaofeng Zhu
Journal:  Dis Markers       Date:  2021-06-12       Impact factor: 3.434

7.  Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation.

Authors:  Xiaodan Shi; Yedong Hu; Bo Zhang; Wenna Li; Jiande Dz Chen; Fei Liu
Journal:  JCI Insight       Date:  2021-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.